Alere Analytics Provides Healthcare Insights on the Future of Patient Engagement at the 2013 NEHI Innovation Conference

  Alere Analytics Provides Healthcare Insights on the Future of Patient
  Engagement at the 2013 NEHI Innovation Conference

  Dr. Fauzia Khan to Share Vision on How Connectivity Technologies Can Help
Providers and Patients Better Manage Their Own Health Across the Continuum of

NEHI Innovation Conference 2013

Business Wire

LOWELL, Mass. -- September 30, 2013

Alere Analytics, an Alere subsidiary specializing in analytics and clinical
decision support (CDS) technology, today announced that Chief Medical Officer
and Co-founder, Dr. Fauzia Khan will participate on an industry panel that
spotlights how connectivity technologies play a crucial rule in engaging
patients and providers at the 2013 NEHI Innovation Conference. The NEHI
Innovation Conference, which is being held at the Seaport Hotel in Boston, MA
on October 3rd, will highlight how senior healthcare leaders and policymakers
are addressing the challenges and opportunities of engaging patients in their
own care.

In Dr. Khan’s panel discussion, she will demonstrate how real-time,
evidence-based decision support, analytics and now mobile patient devices can
more effectively engage patients, enabling personalized and immediate care
recommendations, triggering earlier interventions, and improving overall
clinical outcomes. By providing patient data management across the continuum
of care, including real-time patient surveillance in the hospital/ICU and post
discharge in the home with point-of-care devices, providers would be able to
better manage patient information and identify care gaps in today's fragmented
healthcare environment.

Information About 2013 NEHI Innovation Panel:

When and Where: Thursday, October 3^rd at 1:45 PM at the Seaport Boston Hotel

Track: Making the Connection: Technologies for Engaging Patients & Providers

Panelist: Dr. Fauzia Khan, Chief Medical Officer and Co-Founder, Alere
Analytics, formerly DiagnosisOne

Panel Synopsis: New patient engagement technologies are enabling remote
patient monitoring, medication optimization, and better care coordination.
These new innovations are increasingly available to assist providers and
patients at all points in the care process. However, there is still a need to
better understand how cutting-edge technologies are being evaluated and
implemented for engaging patients and providers alike in health care
decision-making, as well as successfully reducing costs and improving care.

If you are interested in additional insights on patient engagement from Dr.
Fauzia Khan, you can read her article, “Addressing the Empty Seat at the
Healthcare IT Table: Next Steps in Patient Engagement,” that was published in
the June 2013 issue of Becker’s Hospital Review.

About Alere Analytics

Alere Analytics, formerly DiagnosisOne, provides the healthcare industry with
unparalleled analytics and clinical decision support tools based on a single
platform. The company’s analytics and decision support solution leverages the
world's largest library of evidence-based medical knowledge and integrates
seamlessly with existing hospital and laboratory information systems. It
delivers intelligent and actionable information that ensures improved patient
care, fewer errors and better clinical outcomes. Alere Analytics’ customers
include hospitals, healthcare providers, payers, EHR companies, systems
integrators and government entities. Based in Lowell, Mass., Alere Analytics
was formed as DiagnosisOne in 2003 by a team of physicians and healthcare IT
professionals. In July 2012, DiagnosisOne joined Alere, a leading provider of
near-patient diagnostics and health information solutions, and is now
conducting business as Alere Analytics. For more information about the Company
and its solutions, visit

About Alere Inc.

By developing new capabilities in near-patient diagnosis, monitoring and
health information technology, Alere enables individuals to take charge of
improving their health and quality of life at home. Alere's global leading
products and services, as well as its new product development efforts, focus
on cardiology, infectious disease, toxicology and diabetes. Alere is
headquartered in Waltham, Massachusetts. For more information regarding Alere,
please visit


Alere Analytics
Lisa Rivero, 978-856-4600
Press spacebar to pause and continue. Press esc to stop.